One Year After FDA Approval, MiSight 1 Day Contact Lens Mainstreams Myopia Management in the U.S.
Today, CooperVision celebrates 1 year since MiSight 1 day became the first and only FDA approved contact lens for slowing the progression of myopia in children ages 8-12. The milestone and subsequent efforts have vaulted myopia management into mainstream eye care in the United States, including widespread availability of a scientifically proven product.
“This time last year, there was no approved treatment in the U.S. for a health condition that two out of every five Americans face,” Justin Kwan, OD, FAAO, CooperVision Senior Manager of Myopia Management, said in a company news release. “Since the approval of MiSight 1 day, our team has been dedicated to ensuring that ECPs and parents nationwide have both the awareness of and access to this innovative technology and related programs to protect vision as children grow into adults. What was an esoteric area of practice in the recent past has become mainstream.”
In conjunction with the anniversary, CooperVision is opening its Brilliant Futures Myopia Management Program certification to all U.S. ECPs, which will further accelerate adoption of the comprehensive approach to reach thousands more children. The program seeks to elevate the standard of care for age appropriate children by shifting the focus from refractive correction for myopia to interventions that also slow the progression of axial length, the key element in a leading myopia management program. The Brilliant Futures Myopia Management Program accomplishes this by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. ECPs who are interested in beginning certification can learn more here.
Unparalleled Parent Awareness and Education
In August, CooperVision launched a multichannel, direct-to-consumer advertising campaign featuring television actress, producer, and entrepreneur Sarah Michelle Gellar. Believed to be the world’s largest-ever consumer myopia management awareness initiative, its educational messages have generated more than 800 million impressions to date and driven consumers into certified eye care professionals’ offices.
The reality of the prevalence and severity of myopia progression—and what parents can do about it—has entered the daily lives of Americans through their device screens and magazine pages as MiSight 1 day and Brilliant Futures appears across social media platforms Facebook, Instagram, TikTok and others, as well as popular media outlets such as People Magazine, Access Hollywood, and Today.
Nearly 1,000 U.S. children have been fit with MiSight 1 day since the lens became available in March.
Nationwide Adoption of the Brilliant Futures Myopia Management Program
More than 1,500 U.S. ECPs from 46 states are now certified and able to prescribe CooperVision’s Brilliant Futures Myopia Management Program featuring the MiSight 1 day contact lens as its cornerstone. The number surpasses CooperVision’s first year selective participation goals, even as the COVID-19 pandemic introduced new challenges for eye care professionals and their communities.
In addition to opening certification to all U.S. ECPs, CooperVision has also provided access to the faculty and residents of the nation’s 23 schools and colleges of optometry—part of its ongoing commitment to the next generation of ECPs, researchers and educators who will be essential in the fight against myopia progression.
This growth in Brilliant Futures fitters comes as new data emerges from CooperVision’s landmark MiSight 1 day clinical study. Among many powerful outcomes are that nearly one in four children’s eyes originally fit with MiSight 1 day remain stable for myopia after six years. The study previously established the lens to be effective in slowing myopia progression in age-appropriate children by an average of 59% over a three-year period, as measured by spherical refraction.
\